PHIO

#4756
Phio Pharmaceuticals Corp. Common Stock
1.2900 USD
+4.03%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.2900
1.2900
년간 변동
0.9780
1.3500
일일 변동
+4.03%
월간 변동
+6.61%
6달 변화
+8.40%
년간 변동율
+8.40%
이전 종가
1.2400
Open
1.2900
Bid
Ask
Low
1.2900
High
1.2900
양
3
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
Value 202020212022202320242025 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

뉴스